Full-Time

Multi-Skilled Engineer

Posted on 1/5/2026

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Cardiff, UK

In Person

Category
Biology & Biotech (2)
,
Requirements
  • Degree or equivalent qualification in Electrical/Mechanical Engineering.
  • Experience in electrical engineering with a practical, hands-on approach (experience in mechanical engineering will also be considered).
  • Proven ability to thrive in an operational setting and resolve complex technical issues.
  • Strong understanding of preventive maintenance systems (PPM).
  • Excellent problem-solving and project management skills.
  • A team player with strong communication abilities (both verbal and written).
Responsibilities
  • Maintain and service all manufacturing, packaging, and utility equipment involved in product production at PCI Tredegar.
  • Support equipment set-up and changeovers, and provide training to appropriate staff as needed.
  • Diagnose and repair equipment breakdowns efficiently to minimise downtime and product loss, working independently when required.
  • Contribute to and carry out planned preventative maintenance (PPM), ensuring all relevant documentation and SOPs are followed.
  • Monitor and maintain performance of critical utilities and process equipment in a cGMP environment, including repairs, calibrations, and adjustments.
  • Liaise with internal departments and third-party contractors to schedule maintenance and ensure timely completion of associated documentation.
  • Maintain and manage critical spare parts and support vendor coordination for site facilities and utilities maintenance.
  • Assist in the design, procurement, and management of production tooling and building services equipment.
  • Support commissioning, validation, and documentation for new plant and equipment installations.
  • Provide technical support across departments, including troubleshooting, optimal machine settings, and process improvements.
  • Ensure compliance with internal policies, health & safety regulations, and environmental standards at all times.
  • Train and mentor apprentices and team members, promoting professional standards of workmanship.
  • Monitor and help manage electrical energy consumption in line with environmental policies.
  • Support cross-functional collaboration to drive continuous improvement in quality, reliability, and operational performance.
  • Maintain flexibility to support business needs during weekends or outside standard working hours.
Desired Qualifications
  • Background in the pharmaceutical industry (preferred).

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE